Cogent Biosciences (COGT) Short Interest Ratio & Short Volume $11.40 -0.02 (-0.18%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$11.90 +0.50 (+4.43%) As of 08/1/2025 05:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cogent Biosciences Short Interest DataCogent Biosciences (COGT) has a short interest of 13.76 million shares. This marks a 10.97% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.0, indicating that it would take 5.0 days of the average trading volume of 4.80 million shares to cover all short positions.Current Short Interest13,760,000 sharesPrevious Short Interest12,400,000 sharesChange Vs. Previous Month+10.97%Dollar Volume Sold Short$158.24 millionShort Interest Ratio5.0 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares113,860,000 sharesPercentage of Shares Shorted12.09%Today's Trading Volume1,474,464 sharesAverage Trading Volume4,799,851 sharesToday's Volume Vs. Average31% Short Selling Cogent Biosciences? Sign up to receive the latest short interest report for Cogent Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCOGT Short Interest Over TimeCOGT Days to Cover Over TimeCOGT Percentage of Float Shorted Over Time Cogent Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202513,760,000 shares $158.24 million +11.0%N/A5 $11.50 6/30/202512,400,000 shares $89.03 million -24.9%11.7%4.9 $7.18 6/15/202516,520,000 shares $116.96 million +15.4%15.7%9.9 $7.08 5/31/202514,310,000 shares $76.99 million -8.2%13.8%9.9 $5.38 5/15/202515,580,000 shares $74.32 million +6.1%15.0%11.6 $4.77 4/30/202514,680,000 shares $76.48 million +2.4%N/A10.9 $5.21 4/15/202514,330,000 shares $69.79 million +10.2%13.8%10.3 $4.87 3/31/202513,000,000 shares $77.87 million +9.8%12.5%9.1 $5.99 3/15/202511,840,000 shares $84.54 million +1.5%11.4%8.9 $7.14 2/28/202511,660,000 shares $87.80 million +8.0%11.2%7.6 $7.53 Get the Latest News and Ratings for COGT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cogent Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/202510,800,000 shares $86.72 million +6.6%10.4%7.1 $8.03 1/31/202510,130,000 shares $94.31 million +8.3%N/A6.4 $9.31 1/15/20259,350,000 shares $75.92 million +17.2%N/A6 $8.12 12/31/20247,980,000 shares $62.24 million +9.3%N/A5.6 $7.80 12/15/20247,300,000 shares $59.50 million -13.3%N/A5.3 $8.15 11/30/20248,420,000 shares $80.07 million +9.1%N/A6.7 $9.51 11/15/20247,720,000 shares $68.71 million -8.4%N/A7 $8.90 10/31/20248,430,000 shares $96.86 million -1.8%N/A8.3 $11.49 10/15/20248,580,000 shares $100.13 million +3.4%N/A9.4 $11.67 9/30/20248,300,000 shares $89.64 million -14.7%N/A10 $10.80 9/15/20249,730,000 shares $103.43 million -5.1%N/A11.3 $10.63 8/31/202410,250,000 shares $110.09 million +0.2%N/A10.1 $10.74 8/15/202410,230,000 shares $89.21 million +1.2%N/A9.3 $8.72 7/31/202410,110,000 shares $95.34 million -2.7%N/A9.3 $9.43 7/15/202410,390,000 shares $96.11 million +7.3%N/A8.5 $9.25 6/30/20249,680,000 shares $81.60 million -32.4%N/A7.3 $8.43 6/15/202414,320,000 shares $120.65 million -0.6%N/A10.4 $8.43 5/31/202414,400,000 shares $115.34 million +7.0%N/A10.3 $8.01 5/15/202413,460,000 shares $103.91 million +11.8%N/A8.7 $7.72 4/30/202412,040,000 shares $78.26 million -3.5%N/A5.8 $6.50 4/15/202412,470,000 shares $81.06 million +15.0%N/A5.9 $6.50 3/31/202410,840,000 shares $72.84 million +12.6%N/A5 $6.72 3/15/20249,630,000 shares $67.89 million +6.2%N/A4.5 $7.05 2/29/20249,070,000 shares $63.49 million +45.4%N/A3.5 $7.00 2/15/20246,240,000 shares $55.41 million +23.8%N/A2.5 $8.88 1/31/20245,040,000 shares $22.33 million -5.6%N/A2.6 $4.43 1/15/20245,340,000 shares $27.02 million -6.3%N/A3 $5.06 12/31/20235,700,000 shares $33.52 million -22.3%N/A3.5 $5.88 12/15/20237,340,000 shares $35.82 million -8.5%N/A4.8 $4.88 11/30/20238,020,000 shares $61.51 million +1.1%N/A6.3 $7.67Jeff Bezos Launches "ChatGPT Killer"? (Ad)Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% of his time focused on AI… but Nova is only part of the story. Behind the scenes, Amazon has been quietly investing in a breakthrough called “Helios” tech—a core enabler of the $40 trillion AI revolution. While Nova grabs headlines, this technology could be what truly transforms Amazon’s future. But one tiny startup—not Amazon—may offer the bigger upside.Get the name of the small company at the center of the $40 trillion AI boom. 11/15/20237,930,000 shares $60.90 million +23.0%N/A9.4 $7.68 10/31/20236,450,000 shares $52.63 million +6.6%N/A8.3 $8.16 10/15/20236,050,000 shares $57.60 million +4.1%N/A8.3 $9.52 9/30/20235,810,000 shares $56.65 million -9.2%N/A8.5 $9.75 9/15/20236,400,000 shares $75.26 million -4.3%N/A9.5 $11.76 8/31/20236,690,000 shares $81.68 million +4.9%N/A9.8 $12.21 8/15/20236,380,000 shares $78.41 million +24.9%N/A8.7 $12.29 7/31/20235,110,000 shares $66.38 million +4.5%N/A6.9 $12.99 7/15/20234,890,000 shares $61.27 million -7.2%N/A7 $12.53 6/30/20235,270,000 shares $62.40 million -0.9%N/A7.2 $11.84 6/15/20235,320,000 shares $67.09 million +14.7%N/A7 $12.61 5/31/20234,640,000 shares $54.47 million +2.9%N/A6.5 $11.74 5/15/20234,510,000 shares $53.67 million -15.1%N/A7 $11.90 4/30/20235,310,000 shares $57.14 million -5.9%N/A8.5 $10.76 4/15/20235,640,000 shares $57.92 million -8.6%N/A9.5 $10.27 3/31/20236,170,000 shares $66.57 million -3.3%N/A10 $10.79 3/15/20236,380,000 shares $77.58 million +15.2%N/A9.9 $12.16 2/28/20235,540,000 shares $73.29 million +9.5%N/A7.8 $13.23 2/15/20235,060,000 shares $69.42 million +1.6%N/A6.8 $13.72 1/31/20234,980,000 shares $75.00 million -16.2%N/A6.5 $15.06 1/15/20235,940,000 shares $77.40 million +1.9%N/A7.5 $13.03 12/30/20225,830,000 shares $67.39 million +19.7%N/A7.8 $11.56 12/15/20224,870,000 shares $58.25 million -4.7%N/A6.4 $11.96 11/30/20225,110,000 shares $64.28 million +7.1%N/A6.4 $12.58 11/15/20224,770,000 shares $55.86 million +1.9%N/A5.7 $11.71 10/31/20224,680,000 shares $63.88 million -4.9%N/A4.7 $13.65 10/15/20224,920,000 shares $66.96 million -8.9%N/A4.8 $13.61 9/30/20225,400,000 shares $80.57 million +42.5%N/A5.2 $14.92 9/15/20223,790,000 shares $62.27 million +17.7%N/A3.4 $16.43 8/31/20223,220,000 shares $53.10 million -30.6%N/A1 $16.49 8/15/20224,640,000 shares $67.79 million -10.1%N/A1.5 $14.61 7/31/20225,160,000 shares $57.22 million -9.2%N/A1.8 $11.09 7/15/20225,680,000 shares $60.83 million +19.3%N/A2 $10.71 6/30/20224,760,000 shares $42.94 million +9.7%N/A1.7 $9.02 6/15/20224,340,000 shares $36.20 million +99.1%11.9%1.6 $8.34 5/31/20222,180,000 shares $10.05 million +6.9%6.0%6.4 $4.61 5/15/20222,040,000 shares $8.28 million +13.3%5.6%6.4 $4.06 4/30/20221,800,000 shares $11.56 million +20.8%4.8%6.4 $6.42 4/15/20221,490,000 shares $13.02 million -13.9%4.0%6 $8.74 3/31/20221,730,000 shares $12.96 million -7.0%4.6%7.9 $7.49 3/15/20221,860,000 shares $10.30 million +12.1%5.1%11.4 $5.54 2/28/20221,660,000 shares $9.84 million +4.4%5.2%10.2 $5.93 2/15/20221,590,000 shares $11.00 million +9.7%5.0%9.1 $6.92 1/31/20221,450,000 shares $10.96 million +4.3%4.2%5.1 $7.56 1/15/20221,390,000 shares $11.30 million +2.2%4.1%4.7 $8.13 12/31/20211,360,000 shares $11.67 million -2.2%4.0%4.6 $8.58 12/15/20211,390,000 shares $11.50 million +28.7%4.1%4.8 $8.27 11/30/20211,080,000 shares $8.55 million -23.4%3.2%3.7 $7.92 11/15/20211,410,000 shares $14.55 million -20.8%4.1%5 $10.32 10/29/20211,780,000 shares $15.09 million -6.8%5.2%9.3 $8.48Jeff Bezos Launches "ChatGPT Killer"? (Ad)Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% of his time focused on AI… but Nova is only part of the story. Behind the scenes, Amazon has been quietly investing in a breakthrough called “Helios” tech—a core enabler of the $40 trillion AI revolution. While Nova grabs headlines, this technology could be what truly transforms Amazon’s future. But one tiny startup—not Amazon—may offer the bigger upside.Get the name of the small company at the center of the $40 trillion AI boom. 10/15/20211,910,000 shares $17.65 million -9.5%5.6%12.2 $9.24 9/30/20212,110,000 shares $17.75 million -4.1%6.2%12.5 $8.41 9/15/20212,200,000 shares $17.95 million +2.8%6.4%8.7 $8.16 8/31/20212,140,000 shares $17.72 million +0.5%6.2%7 $8.28 8/13/20212,130,000 shares $16.83 million +4.4%6.2%7.2 $7.90 7/30/20212,040,000 shares $12.24 million -1.0%5.8%7.1 $6.00 7/15/20212,060,000 shares $13.95 million +4.6%5.9%6.6 $6.77 6/30/20211,970,000 shares $15.98 million +34.0%5.6%5.9 $8.11 6/15/20211,470,000 shares $13.32 million -0.7%4.2%5.5 $9.06 5/28/20211,480,000 shares $12.82 million -4.5%4.2%5.5 $8.66 5/14/20211,550,000 shares $12.32 million -34.9%4.4%4.7 $7.95 4/30/20212,380,000 shares $20.44 million +0.4%6.9%6.5 $8.59 4/15/20212,370,000 shares $20.93 million -16.0%7.1%5.8 $8.83 3/31/20212,820,000 shares $23.52 million +8.9%8.5%6.9 $8.34 3/15/20212,590,000 shares $21.19 million +19.4%7.4%5.7 $8.18 2/26/20212,170,000 shares $17.79 million +42.8%3.8%4.6 $8.20 2/12/20211,520,000 shares $15.05 million +54.0%2.6%3.1 $9.90 1/29/2021987,300 shares $8.97 million +31.6%3.9%2.2 $9.09 1/15/2021750,000 shares $8.93 million No Change1.5%1.8 $11.90 COGT Short Interest - Frequently Asked Questions What is Cogent Biosciences' current short interest? Short interest is the volume of Cogent Biosciences shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 13,760,000 shares of COGT short. Learn More on Cogent Biosciences' current short interest. What is a good short interest ratio for Cogent Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. COGT shares currently have a short interest ratio of 5.0. Learn More on Cogent Biosciences's short interest ratio. Which institutional investors are shorting Cogent Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cogent Biosciences: Caption Management LLC, and Persistent Asset Partners Ltd. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cogent Biosciences' short interest increasing or decreasing? Cogent Biosciences saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 13,760,000 shares, an increase of 11.0% from the previous total of 12,400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cogent Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cogent Biosciences: Lantheus Holdings, Inc. (12.25%), Axsome Therapeutics, Inc. (7.37%), Vaxcyte, Inc. (10.56%), Merus N.V. (6.56%), Cytokinetics, Incorporated (13.64%), Avidity Biosciences, Inc. (13.49%), ADMA Biologics Inc (6.06%), Krystal Biotech, Inc. (10.87%), Abivax SA Sponsored ADR (2.57%), Zai Lab Limited Unsponsored ADR (3.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Cogent Biosciences stock? Short selling COGT is an investing strategy that aims to generate trading profit from Cogent Biosciences as its price is falling. COGT shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cogent Biosciences? A short squeeze for Cogent Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of COGT, which in turn drives the price of the stock up even further. How often is Cogent Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including COGT, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies LNTH Short Squeeze AXSM Short Squeeze PCVX Short Squeeze MRUS Short Squeeze CYTK Short Squeeze RNA Short Squeeze ADMA Short Squeeze KRYS Short Squeeze ABVX Short Squeeze ZLAB Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:COGT) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cogent Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
